Cargando…
Therapeutic Prospect of New Probiotics in Neurodegenerative Diseases
Increasing clinical and preclinical evidence implicates gut microbiome (GM) dysbiosis as a key susceptibility factor for neurodegenerative disorders, including Alzheimer’s disease (AD) and Parkinson’s disease (PD). In recent years, neurodegenerative diseases have been viewed as being driven not sole...
Autores principales: | Bi, Mingxia, Liu, Chang, Wang, Yulin, Liu, Shuang-Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303039/ https://www.ncbi.nlm.nih.gov/pubmed/37375029 http://dx.doi.org/10.3390/microorganisms11061527 |
Ejemplares similares
-
The emerging role of probiotics in neurodegenerative diseases: new hope for Parkinson’s disease?
por: Castelli, Vanessa, et al.
Publicado: (2020) -
Probiotics for Neurodegenerative Diseases: A Systemic Review
por: Ojha, Sandhya, et al.
Publicado: (2023) -
Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases
por: Ma, Ya-Min, et al.
Publicado: (2023) -
Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes
por: Wang, Yumin, et al.
Publicado: (2023) -
Polyoxidovanadates a new therapeutic alternative for neurodegenerative and aging diseases
por: Gonzalez-Cano, Sonia Irais, et al.
Publicado: (2023)